MCBI
MCBI is a company dedicated to exploring biomarkers for preemptive medicine, aiming to realize a society where people can live healthily and happily. They focus on early detection and prevention of diseases, especially dementia, through research and development of blood-based biomarkers and genetic testing. Their mission is to support individuals in living healthy and happy lives by advancing early diagnosis and preventive healthcare.
Industries
Nr. of Employees
small (1-50)
Products
MCI screening blood test (multi‑protein LC‑MS panel)
Laboratory test that quantifies a set of blood proteins related to Alzheimer’s-type pathology to estimate risk of mild cognitive impairment (MCI) and track changes over time.
APOE genotype test
Genetic test to determine APOE allele combinations (e.g., ε2/ε3/ε4) used to assess relative genetic susceptibility to Alzheimer’s disease and related treatment risk considerations.
MCI screening blood test (multi‑protein LC‑MS panel)
Laboratory test that quantifies a set of blood proteins related to Alzheimer’s-type pathology to estimate risk of mild cognitive impairment (MCI) and track changes over time.
APOE genotype test
Genetic test to determine APOE allele combinations (e.g., ε2/ε3/ε4) used to assess relative genetic susceptibility to Alzheimer’s disease and related treatment risk considerations.
Services
Blood‑based preventive diagnostic testing (MCI risk evaluation)
Clinical laboratory service that measures a multi‑protein blood panel to evaluate MCI/cognitive decline risk and provide longitudinal risk tracking.
APOE genetic risk testing
Genetic testing service to determine APOE genotype for assessment of lifetime Alzheimer's disease risk and treatment‑related risk considerations.
Joint research and intervention effect‑measurement support
Collaborative research service offering study design, biomarker measurement, data analysis and interpretation to evaluate efficacy of products or programs (e.g., beverages, supplements, exercise).
Dementia prevention education and public outreach
Provision of educational materials, web content and community prevention classes to increase public understanding of dementia and actionable prevention measures.
Clinical research coordination and site support
Operational support for clinical studies including participant recruitment, site coordination, sample logistics, and interactions with clinical research coordinators.
Blood‑based preventive diagnostic testing (MCI risk evaluation)
Clinical laboratory service that measures a multi‑protein blood panel to evaluate MCI/cognitive decline risk and provide longitudinal risk tracking.
APOE genetic risk testing
Genetic testing service to determine APOE genotype for assessment of lifetime Alzheimer's disease risk and treatment‑related risk considerations.
Joint research and intervention effect‑measurement support
Collaborative research service offering study design, biomarker measurement, data analysis and interpretation to evaluate efficacy of products or programs (e.g., beverages, supplements, exercise).
Dementia prevention education and public outreach
Provision of educational materials, web content and community prevention classes to increase public understanding of dementia and actionable prevention measures.
Clinical research coordination and site support
Operational support for clinical studies including participant recruitment, site coordination, sample logistics, and interactions with clinical research coordinators.
Expertise Areas
- Biomarker discovery and validation
- Blood‑based diagnostics and proteomics
- Clinical trial design and longitudinal study execution
- Effect measurement for preventive interventions
Key Technologies
- Liquid chromatography–mass spectrometry (LC‑MS)
- Proteomic multi‑protein biomarker panels
- Genotyping (APOE)
- Functional near‑infrared spectroscopy (fNIRS)